FAM76A
gene geneOn this page
Also known as MGC34648
Summary
FAM76A (family with sequence similarity 76 member A, HGNC:28530) is a protein-coding gene on chromosome 1p35.3, encoding Protein FAM76A (Q8TAV0).
Located in nucleoplasm.
Source: NCBI Gene 199870 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 31 total — 1 pathogenic
- MANE Select transcript:
NM_152660
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28530 |
| Approved symbol | FAM76A |
| Name | family with sequence similarity 76 member A |
| Location | 1p35.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC34648 |
| Ensembl gene | ENSG00000009780 |
| Ensembl biotype | protein_coding |
| Entrez | 199870 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 protein_coding
ENST00000010299, ENST00000234549, ENST00000373949, ENST00000373954, ENST00000419687, ENST00000446647, ENST00000530324, ENST00000894823, ENST00000894824, ENST00000912089, ENST00000944839
RefSeq mRNA: 5 — MANE Select: NM_152660
NM_001143912, NM_001143913, NM_001143914, NM_001143915, NM_152660
CCDS: CCDS309, CCDS44092, CCDS44093, CCDS44094, CCDS44095
Canonical transcript exons
ENST00000373954 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000327880 | 27732603 | 27732657 |
| ENSE00000761751 | 27759526 | 27759627 |
| ENSE00000761753 | 27749068 | 27749154 |
| ENSE00000761780 | 27744654 | 27744811 |
| ENSE00000866714 | 27755195 | 27755330 |
| ENSE00000866716 | 27734031 | 27734183 |
| ENSE00001206834 | 27725961 | 27726161 |
| ENSE00001287810 | 27760495 | 27763116 |
| ENSE00001625313 | 27727472 | 27727536 |
Expression profiles
Bgee: expression breadth ubiquitous, 252 present calls, max score 91.60.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.1470 / max 112.5685, expressed in 1800 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1741 | 10.9193 | 1787 |
| 1742 | 4.2233 | 1622 |
| 1740 | 0.0045 | 2 |
Top tissues by expression
272 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.60 | gold quality |
| calcaneal tendon | UBERON:0003701 | 88.73 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.40 | gold quality |
| sural nerve | UBERON:0015488 | 85.25 | gold quality |
| right testis | UBERON:0004534 | 84.74 | gold quality |
| left testis | UBERON:0004533 | 84.72 | gold quality |
| testis | UBERON:0000473 | 84.43 | gold quality |
| secondary oocyte | CL:0000655 | 83.77 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 83.45 | gold quality |
| right uterine tube | UBERON:0001302 | 82.55 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 82.52 | gold quality |
| monocyte | CL:0000576 | 82.49 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 82.46 | gold quality |
| leukocyte | CL:0000738 | 82.38 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 82.31 | gold quality |
| upper arm skin | UBERON:0004263 | 82.14 | silver quality |
| islet of Langerhans | UBERON:0000006 | 82.00 | gold quality |
| oocyte | CL:0000023 | 81.99 | gold quality |
| rectum | UBERON:0001052 | 81.97 | gold quality |
| thyroid gland | UBERON:0002046 | 81.97 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 81.92 | gold quality |
| mucosa of stomach | UBERON:0001199 | 81.87 | gold quality |
| tibial artery | UBERON:0007610 | 81.58 | gold quality |
| ectocervix | UBERON:0012249 | 81.58 | gold quality |
| popliteal artery | UBERON:0002250 | 81.56 | gold quality |
| tendon | UBERON:0000043 | 81.48 | gold quality |
| body of uterus | UBERON:0009853 | 81.48 | gold quality |
| skin of abdomen | UBERON:0001416 | 81.34 | gold quality |
| granulocyte | CL:0000094 | 81.27 | gold quality |
| skin of leg | UBERON:0001511 | 81.23 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.05 |
| E-GEOD-83139 | no | 2.74 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
101 targeting FAM76A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6755-5P | 99.95 | 65.59 | 464 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam76a | ENSMUSG00000028878 |
| rattus_norvegicus | Fam76a | ENSRNOG00000011254 |
| drosophila_melanogaster | CG4452 | FBGN0035981 |
| caenorhabditis_elegans | K04F10.7 | WBGENE00019399 |
Paralogs (2): FAM76B (ENSG00000077458), SENP8 (ENSG00000166192)
Protein
Protein identifiers
Protein FAM76A — Q8TAV0 (reviewed: Q8TAV0)
All UniProt accessions (3): Q8TAV0, B1AJQ5, E9PQL1
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM76 family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TAV0-1 | 1 | yes |
| Q8TAV0-2 | 2 | |
| Q8TAV0-3 | 3 | |
| Q8TAV0-4 | 4 | |
| Q8TAV0-5 | 5 |
RefSeq proteins (5): NP_001137384, NP_001137385, NP_001137386, NP_001137387, NP_689873* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032017 | FAM76 | Family |
Pfam: PF16046
UniProt features (8 total): splice variant 3, region of interest 2, chain 1, coiled-coil region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TAV0-F1 | 79.24 | 0.54 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 145 (showing top):
PAX4_01, AP2_Q3, PUJANA_CHEK2_PCC_NETWORK, GTGCCTT_MIR506, CYTAGCAAY_UNKNOWN, GATA1_04, SCHLOSSER_SERUM_RESPONSE_DN, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, CCAGGTT_MIR490, CUI_TCF21_TARGETS_2_DN, CREBP1_01, CTTTGTA_MIR524, AP2_Q6_01, AP2GAMMA_01, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): nucleoplasm (GO:0005654), nuclear speck (GO:0016607)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| nuclear ribonucleoprotein granule | 1 |
Protein interactions and networks
STRING
200 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM76A | CCDC12 | Q8WUD4 | 685 |
| FAM76A | NPIPA7 | E9PJI5 | 654 |
| FAM76A | DYRK1B | Q9Y463 | 489 |
| FAM76A | CIMAP1D | Q3SX64 | 475 |
| FAM76A | MPDU1 | O75352 | 446 |
| FAM76A | NRBP1 | Q9UHY1 | 442 |
| FAM76A | ETFRF1 | Q6IPR1 | 419 |
| FAM76A | RBM42 | Q9BTD8 | 419 |
| FAM76A | PPP1R8 | Q12972 | 405 |
| FAM76A | TMEM138 | Q9NPI0 | 395 |
| FAM76A | TC2N | Q8N9U0 | 374 |
| FAM76A | PLEKHB2 | Q96CS7 | 367 |
| FAM76A | DYRK1A | Q13627 | 355 |
| FAM76A | FKBP7 | Q9Y680 | 352 |
| FAM76A | PRPF18 | Q99633 | 348 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPTLC1 | SPTLC2 | psi-mi:“MI:0914”(association) | 0.680 |
| FAM76A | SMC3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KMT5C | CBX4 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (38): SMC3 (Proximity Label-MS), FAM76A (Affinity Capture-MS), NSRP1 (Affinity Capture-MS), FAM76B (Affinity Capture-MS), G3BP2 (Affinity Capture-MS), TOX4 (Affinity Capture-MS), PPP1R10 (Affinity Capture-MS), YY1 (Affinity Capture-MS), CCNL1 (Affinity Capture-MS), FAM76A (Affinity Capture-MS), PRPF40A (Affinity Capture-MS), PRPF4B (Affinity Capture-MS), FAM76A (Affinity Capture-MS), FAM76A (Affinity Capture-MS), MFAP1 (Affinity Capture-MS)
ESM2 similar proteins: A4FVD8, A5D7H2, O14795, O43237, O55047, O70585, O75446, O88574, P58405, P84060, Q02241, Q0VA03, Q13033, Q14161, Q28H91, Q2TAD4, Q4KUS2, Q4R5P6, Q5EA89, Q5HYJ3, Q5R7U7, Q5RE09, Q5SQF8, Q5ZJ65, Q62768, Q6NYV5, Q6PBM7, Q6PDL0, Q80XP8, Q80YA9, Q811S7, Q86UE8, Q8BIK4, Q8C0V0, Q8CBY8, Q8TAV0, Q8WXI2, Q90ZY6, Q922G2, Q96EZ8
Diamond homologs: Q566M1, Q5EA89, Q5HYJ3, Q5ZJ65, Q6DEE7, Q6PBM7, Q80XP8, Q8TAV0, Q922G2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 4279402 | GRCh37/hg19 1p36.11-35.3(chr1:27408121-28103364)x1 | Pathogenic |
SpliceAI
1451 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:27726158:CAAGG:C | donor_loss | 1.0000 |
| 1:27726160:AGG:A | donor_loss | 1.0000 |
| 1:27726161:GGTG:G | donor_loss | 1.0000 |
| 1:27726162:G:GA | donor_loss | 1.0000 |
| 1:27727516:GAC:G | donor_gain | 1.0000 |
| 1:27727533:A:T | donor_gain | 1.0000 |
| 1:27732601:A:AG | acceptor_gain | 1.0000 |
| 1:27732602:G:GA | acceptor_gain | 1.0000 |
| 1:27732602:GT:G | acceptor_gain | 1.0000 |
| 1:27732602:GTA:G | acceptor_gain | 1.0000 |
| 1:27732602:GTAAA:G | acceptor_gain | 1.0000 |
| 1:27734028:A:AG | acceptor_gain | 1.0000 |
| 1:27734029:A:AT | acceptor_loss | 1.0000 |
| 1:27734029:A:G | acceptor_gain | 1.0000 |
| 1:27734030:G:GG | acceptor_gain | 1.0000 |
| 1:27734030:G:GT | acceptor_loss | 1.0000 |
| 1:27734030:GCC:G | acceptor_gain | 1.0000 |
| 1:27734030:GCCC:G | acceptor_gain | 1.0000 |
| 1:27734030:GCCCA:G | acceptor_gain | 1.0000 |
| 1:27734166:A:T | donor_gain | 1.0000 |
| 1:27734180:GAAG:G | donor_gain | 1.0000 |
| 1:27734184:G:GA | donor_loss | 1.0000 |
| 1:27734185:T:A | donor_loss | 1.0000 |
| 1:27744652:A:AC | acceptor_loss | 1.0000 |
| 1:27744653:G:GT | acceptor_loss | 1.0000 |
| 1:27744653:GGT:G | acceptor_gain | 1.0000 |
| 1:27744653:GGTA:G | acceptor_gain | 1.0000 |
| 1:27750203:G:GT | donor_gain | 1.0000 |
| 1:27755327:GAAG:G | donor_gain | 1.0000 |
| 1:27755328:AAG:A | donor_loss | 1.0000 |
AlphaMissense
2030 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:27726099:T:C | C7R | 1.000 |
| 1:27726100:G:A | C7Y | 1.000 |
| 1:27726101:C:G | C7W | 1.000 |
| 1:27726108:T:C | C10R | 1.000 |
| 1:27726136:T:C | L19P | 1.000 |
| 1:27726154:T:C | L25P | 1.000 |
| 1:27726156:T:A | C26S | 1.000 |
| 1:27726156:T:C | C26R | 1.000 |
| 1:27726157:G:A | C26Y | 1.000 |
| 1:27726157:G:C | C26S | 1.000 |
| 1:27726158:C:G | C26W | 1.000 |
| 1:27727475:T:A | C29S | 1.000 |
| 1:27727475:T:C | C29R | 1.000 |
| 1:27727476:G:C | C29S | 1.000 |
| 1:27727502:T:A | C38S | 1.000 |
| 1:27727502:T:C | C38R | 1.000 |
| 1:27727503:G:A | C38Y | 1.000 |
| 1:27727503:G:C | C38S | 1.000 |
| 1:27727503:G:T | C38F | 1.000 |
| 1:27727504:C:G | C38W | 1.000 |
| 1:27727511:T:A | C41S | 1.000 |
| 1:27727511:T:C | C41R | 1.000 |
| 1:27727512:G:A | C41Y | 1.000 |
| 1:27727512:G:C | C41S | 1.000 |
| 1:27727512:G:T | C41F | 1.000 |
| 1:27727513:C:G | C41W | 1.000 |
| 1:27727515:G:C | R42T | 1.000 |
| 1:27727515:G:T | R42M | 1.000 |
| 1:27727516:G:C | R42S | 1.000 |
| 1:27727516:G:T | R42S | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000133444 (1:27752143 A>G), RS1000174589 (1:27724396 T>A,G), RS1000213501 (1:27749394 G>C,T), RS1000265108 (1:27743361 C>T), RS1000337701 (1:27743654 A>G), RS1000455933 (1:27736878 C>T), RS1000559580 (1:27726707 G>A,T), RS1000564132 (1:27749568 G>T), RS1000588737 (1:27751587 C>T), RS1000673039 (1:27742103 A>T), RS1000830864 (1:27739716 A>G), RS1000847628 (1:27737168 C>G,T), RS1000927266 (1:27762485 G>A), RS1000959494 (1:27748126 T>G), RS1000980361 (1:27746389 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects methylation, decreases expression | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| triphenyl phosphate | affects expression | 1 |
| butyraldehyde | decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | decreases expression, affects cotreatment | 1 |
| abrine | decreases expression | 1 |
| bisphenol S | affects cotreatment, increases expression | 1 |
| Bortezomib | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.